Skip to main content
. Author manuscript; available in PMC: 2024 Aug 1.
Published in final edited form as: Neurourol Urodyn. 2023 Jun 3;42(6):1214–1226. doi: 10.1002/nau.25222

Figure 3.

Figure 3.

Results from Cox proportional hazard model predicting time to OAB medication discontinuation from medication initiation or from baseline if participant started medication before baseline. (a) Predicted probability of continuing OAB medication after 6 months. Participants censored before 6 months were excluded from this plot, as their true medication continuation status at 6-month was unknown. (b) Calibration curve.